C
바이오비쥬
489460KOSDAQ54.5 / 100
Reference Date: 2026-10-23
Financial Score18.0 / 40
News Sentiment12.5 / 25
Momentum14.0 / 20
Disclosure10.0 / 15
AI Analysis: the debt ratio is very low with excellent financial health but PER raises overvaluation concerns. Roughly flat over the past month, with no recent news.
Company InformationBased on 2025 Annual Report
Business Overview
BioViju is a global export-focused company specializing in the research, development, and manufacturing of hyaluronic acid (HA)-based skin boosters and fillers, utilizing cross-linking and LNP technologies to ensure product safety. With its own production facility and ISO certification, the company is expanding OEM and general distribution, aiming to secure growth momentum through the expansion of HA filler approvals both domestically and internationally.
Number of Employees
51people
Average Salary
49.7M KRW
Score Calculation Basis
Detailed Financial Score
PER
38.86Industry Average 15.000.0Point
2.6x industry avg (risky)
PBR
2.76Industry Average 1.200.0Point
2.3x industry avg (risky)
ROE
8.94Industry Average 8.004.0Point
In line with industry avg
Debt Ratio
0.31Industry Average 100.008.0Point
Half of industry avg (excellent)
Trend 6.0 / 10 points
Revenue Growth Rate
1.5 / 3
Operating Profit Growth Rate
1.5 / 3
ROE Trend
3.0 / 4
Detailed News Sentiment
0 totalPositive 0Neutral 0Negative 0
Detailed Momentum
52-week position5.0Point
52w mid range (58%)
Current 11,580Won52-week high 15,82052-week low 5,530
1-month return3.0Point
1m -0.26% (flat)
Volume trend6.0Point
Volume surge
Detailed Disclosure
1 totalPositive 0Neutral 1Negative 0
- Neutral주식등의대량보유상황보고서(약식)2026-10-02